SCHEMBL16270970

SCHEMBL16270970

Oc1nnc(I)cc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624258 0.74 — —
SCHEMBL15759801 0.67 — —
SCHEMBL17388839 0.67 — —
SCHEMBL17703508 0.63 — —
SCHEMBL7842355 0.59 — —
SCHEMBL29317925 0.59 — —
SCHEMBL7849940 0.59 — —
SCHEMBL356254 0.58 NQO1 (0.32) —
SCHEMBL14155725 0.57 — —
SCHEMBL255651 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020252229-A2 INHIBITORS OF SARM1 DISARM THERAPEUTICS, INC. (US) 2020-12-17 — — WO disclosed
EP-2539323-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2014-12-03 — — EP disclosed
Send feedback